X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6351) 6351
Newsletter (640) 640
Publication (466) 466
Newspaper Article (358) 358
Book Chapter (97) 97
Book Review (64) 64
Book / eBook (61) 61
Magazine Article (11) 11
Trade Publication Article (9) 9
Web Resource (9) 9
Transcript (8) 8
Dissertation (5) 5
Conference Proceeding (3) 3
Data Set (2) 2
Reference (2) 2
Presentation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4342) 4342
lymphomas (2893) 2893
male (2672) 2672
female (2475) 2475
middle aged (2178) 2178
index medicus (2078) 2078
aged (1806) 1806
adult (1698) 1698
oncology (1507) 1507
surgery (1418) 1418
chemotherapy (1344) 1344
cancer (1270) 1270
lymphoma (1245) 1245
lymphoma, large b-cell, diffuse - pathology (990) 990
diagnosis (950) 950
research (918) 918
care and treatment (912) 912
pathology (900) 900
prognosis (871) 871
non-hodgkin's lymphomas (777) 777
hematology (767) 767
non-hodgkins-lymphoma (751) 751
lymphoma, large b-cell, diffuse - surgery (712) 712
b-cell lymphoma (700) 700
aged, 80 and over (692) 692
tumors (685) 685
antineoplastic combined chemotherapy protocols - therapeutic use (666) 666
hemic and lymphatic diseases (640) 640
treatment outcome (628) 628
immunohistochemistry (612) 612
diagnosis, differential (601) 601
biopsy (578) 578
patients (577) 577
lymphoma, large b-cell, diffuse - diagnosis (576) 576
adolescent (574) 574
case report (520) 520
retrospective studies (520) 520
lymphoma, large b-cell, diffuse - drug therapy (486) 486
health aspects (480) 480
combined modality therapy (463) 463
disease (442) 442
rituximab (420) 420
tomography, x-ray computed (389) 389
leukemia (387) 387
lymphoma, b-cell - pathology (384) 384
child (381) 381
medical prognosis (376) 376
immune system diseases (374) 374
diffuse large b-cell lymphoma (372) 372
case studies (371) 371
medicine (357) 357
malignant-lymphoma (349) 349
risk factors (344) 344
transplantation (335) 335
neoplasm staging (333) 333
analysis (328) 328
follow-up studies (326) 326
cancer therapies (324) 324
lymphoma, non-hodgkin - pathology (321) 321
survival (321) 321
young adult (320) 320
magnetic resonance imaging (307) 307
expression (301) 301
lymphoma, large b-cell, diffuse - complications (301) 301
lymphoma, large b-cell, diffuse - therapy (287) 287
classification (281) 281
lymphoma - pathology (281) 281
medical research (277) 277
lymphocytes (276) 276
development and progression (271) 271
radiation therapy (267) 267
non-hodgkin's lymphoma (264) 264
radiotherapy (264) 264
metastasis (258) 258
usage (252) 252
bone marrow (248) 248
stem cells (247) 247
therapy (246) 246
medicine & public health (243) 243
gene expression (239) 239
medical imaging (239) 239
studies (237) 237
disease-free survival (236) 236
cyclophosphamide - administration & dosage (233) 233
lymphatic system (232) 232
animals (229) 229
genetic aspects (225) 225
antineoplastic agents - therapeutic use (224) 224
fatal outcome (221) 221
sarcoma (219) 219
vincristine - administration & dosage (219) 219
proteins (211) 211
doxorubicin - administration & dosage (209) 209
lymphoma, b-cell - diagnosis (208) 208
gastroenterology & hepatology (207) 207
neoplasms (207) 207
survival analysis (206) 206
lymphoma, non-hodgkin - surgery (205) 205
patient outcomes (204) 204
research article (202) 202
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Scarborough Hospital - General (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6902) 6902
Japanese (155) 155
German (111) 111
French (77) 77
Chinese (66) 66
Italian (56) 56
Russian (50) 50
Spanish (33) 33
Polish (26) 26
Korean (24) 24
Turkish (10) 10
Danish (6) 6
Portuguese (6) 6
Bulgarian (5) 5
Czech (4) 4
Dutch (4) 4
Hungarian (4) 4
Romanian (4) 4
Slovak (3) 3
Finnish (2) 2
Arabic (1) 1
Croatian (1) 1
Hebrew (1) 1
Latvian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4184 - 4190
Purpose Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large... 
SURVIVAL | PARMA TRIAL | THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | NON-HODGKINS-LYMPHOMA | CHOP | AGGRESSIVE LYMPHOMA | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Recurrence | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | New York City | Stem Cell Transplantation | Young Adult | Time Factors | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Antigens, CD20 - analysis | Chemotherapy, Adjuvant | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Rituximab | Etoposide - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Ifosfamide - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Israel | Australia | Neoplasm Staging | Bone2 | Original Reports | Hema13 | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Surgery | Onkologi | Oncology | Cancer and Oncology | Klinisk medicin | MEDICINE | Kirurgi | Cancer och onkologi
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2013, Volume 162, Issue 6, pp. 774 - 782
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 20, pp. 4256 - 4262
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 02/2016, Volume 16, Issue 2, pp. 414 - 425
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 11/2015, Volume 39, Issue 11, pp. 1493 - 1501
Journal Article
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 6, pp. 1958 - 1965
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2236 - 2244
Primary breast lymphoma is a rare form of non-Hodgkin lymphoma with some distinct clinical features. The most common histopathological type is diffuse large... 
DLBCL | Breast lymphoma | Primary breast lymphoma (PBL) | CNS prophylaxis | Combined modality therapy | Diffuse large B-cell lymphoma | PROGNOSTIC-FACTORS | diffuse large B-cell lymphoma | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | ONCOLOGY | MALE-PATIENT | primary breast lymphoma (PBL) | combined modality therapy | NON-HODGKINS-LYMPHOMA | LOCALIZED AGGRESSIVE LYMPHOMA | CENTRAL-NERVOUS-SYSTEM | MABTHERA INTERNATIONAL TRIAL | ELDERLY-PATIENTS | breast lymphoma | Breast Neoplasms - surgery | Doxorubicin - therapeutic use | Prognosis | Humans | Middle Aged | Central Nervous System - pathology | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Female | Breast - pathology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Lymphoma, Large B-Cell, Diffuse - pathology | Rituximab | Treatment Outcome | Combined Modality Therapy | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Vincristine - therapeutic use | Central Nervous System - drug effects | Aged | Neoplasm Staging | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2013, Volume 163, Issue 3, pp. 334 - 342
This international, multicentre phase II study was conducted to assess ofatumumab, a human anti‐ CD 20 monoclonal antibody, in patients with... 
haematological malignancies | non‐Hodgkin lymphoma | diffuse large B‐cell lymphoma | lymphoid malignancies | immunotherapy | Non-Hodgkin lymphoma | Haematological malignancies | Lymphoid malignancies | Immunotherapy | Diffuse large B-cell lymphoma | CD20 | REFRACTORY FOLLICULAR LYMPHOMA | ANTI-CD20 MONOCLONAL-ANTIBODY | RITUXIMAB | CHOP | non-Hodgkin lymphoma | diffuse large B-cell lymphoma | HEMATOLOGY | ELDERLY-PATIENTS | Recurrence | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Salvage Therapy | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents, Alkylating - pharmacology | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents, Alkylating - administration & dosage | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antibodies, Monoclonal - immunology | Antigens, CD20 - immunology | Hematologic Diseases - chemically induced | Lymphoma, Large B-Cell, Diffuse - surgery | Kaplan-Meier Estimate | Antibodies, Monoclonal - pharmacokinetics | Hematopoietic Stem Cell Transplantation | Rituximab | Combined Modality Therapy | Remission Induction | Immunotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Clinical trials | Monoclonal antibodies | Lymphomas | Stem cells | Autografts
Journal Article